You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Synergistic Anti-cancer Activity

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Malignant Tumor, Metastatic Malignant Tumor, Recurrent Malignant Tumor Trial in Houston (Laboratory Biomarker Analysis,

Active, not recruiting
  • Advanced Malignant Neoplasm
  • +2 more
  • Laboratory Biomarker Analysis
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 13, 2022

NSCLC Trial in Busan (GDC-6036, Pembrolizumab)

Recruiting
  • Non-Small Cell Lung Cancer
  • Busan, Korea, Republic of
    Pusan National University Hospital
Apr 3, 2023

Prostate Cancer Trial in Beijing, Nanjing (QLH12016)

Not yet recruiting
  • Prostate Cancer
  • Beijing, Beijign, China
  • +1 more
Jul 25, 2023

Solid Tumor, Adult, Solid Tumor, Gastric Cancer Trial in Seongnam, Seoul (PB101)

Recruiting
  • Solid Tumor, Adult
  • +5 more
  • Seongnam, Korea, Republic of
  • +2 more
Oct 11, 2023

Small Cell Lung Cancer, Neuroendocrine Carcinoma Trial in Chiba, Tokyo (RO7616789, Tocilizumab)

Recruiting
  • Small Cell Lung Cancer
  • Neuroendocrine Carcinoma
  • Chiba, Japan
  • +1 more
Jan 16, 2023

Prostate Cancer Trial in Boston (ARN-509, Abiraterone acetate, Prednisone)

Active, not recruiting
  • Prostate Cancer
  • Boston, Massachusetts
    (unnamed)
Jan 17, 2023

Metastatic Castration Resistant Prostate Cancer Trial in London (IMU-935)

Recruiting
  • Metastatic Castration Resistant Prostate Cancer
  • London, United Kingdom
    Institute of Cancer Research
Jan 31, 2023

Metastatic Castration-resistant Prostate Cancer Trial (HP518 - Dose Escalation, HP518 -Dose Expansion)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • HP518 - Dose Escalation
  • HP518 -Dose Expansion
  • (no location specified)
Dec 1, 2023

MSI-H/dMMR Gastroesophageal-junction Cancer, MSI-H/dMMR Gastric Cancer Trial (S095029, Pembrolizumab 200 mg)

Not yet recruiting
  • MSI-H/dMMR Gastroesophageal-junction Cancer
  • MSI-H/dMMR Gastric Cancer
  • (no location specified)
Oct 30, 2023

Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, mCRPC Trial in Glen Burnie (177Lu-rhPSMA-10.1 injection,

Recruiting
  • Prostate Cancer
  • +5 more
  • 177Lu-rhPSMA-10.1 injection
  • 18F-rhPSMA-7.3 injection
  • Glen Burnie, Maryland
  • +3 more
Feb 2, 2023

Prostate Cancer Trial (activity sessions)

Not yet recruiting
  • Prostate Cancer
  • activity sessions
  • (no location specified)
Feb 24, 2023

Prostate Cancer, mCRPC Trial in Seoul (Lu-177-DGUL, Ga-68-NGUL)

Recruiting
  • Prostate Cancer
  • mCRPC
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Sep 22, 2022

Breast Cancer, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Portland, Suwon (AB-201, Cyclophosphamide,

Not yet recruiting
  • Breast Cancer
  • +2 more
  • Portland, Oregon
  • +1 more
Jan 12, 2023

Melanoma (Skin), Triple-Negative Breast Cancer, NSCLC Trial (PeptiCRAd-1, Cyclophosphamide, Pembrolizumab)

Not yet recruiting
  • Melanoma (Skin)
  • +2 more
  • (no location specified)
Aug 5, 2022

Peripheral T Cell Lymphoma Trial in Zhengzhou (Golidocitinib, CHOP Regimen)

Not yet recruiting
  • Peripheral T Cell Lymphoma
  • Zhengzhou, Henan, China
    Henan Cancer Hospital
Jul 18, 2023

Non-muscle Invasive Bladder Cancer Trial (TARA-002)

Not yet recruiting
  • Non-muscle Invasive Bladder Cancer
  • TARA-002
  • (no location specified)
Jul 14, 2023

Non Small Cell Lung Cancer Trial in China (AZD3759)

Completed
  • Non Small Cell Lung Cancer
  • Guangzhou, Guangdong, China
  • +3 more
Nov 22, 2022

ER+ HER2- Advanced Breast Cancer Trial in Chuo-ku, Kashiwa, Koto-ku (AZD9833)

Active, not recruiting
  • ER+ HER2- Advanced Breast Cancer
  • Chuo-ku, Japan
  • +2 more
Jan 24, 2023

Advanced or Metastatic Solid Tumors Trial in Australia (AK119, AK104)

Active, not recruiting
  • Advanced or Metastatic Solid Tumors
  • AK119
  • AK104
  • Blacktown, New South Wales, Australia
  • +4 more
Jan 5, 2023

Renal Cell Carcinoma, NSCLC, Pancreatic Adenocarcinoma, Colorectal Cancer Trial (RO7515629, tocilizumab)

Not yet recruiting
  • Renal Cell Carcinoma, Non-small Cell Lung Cancer, Pancreatic Adenocarcinoma, Colorectal Cancer
  • (no location specified)
Mar 3, 2023

Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial in Bellinzona, London Borough of Sutton (Enzalutamide 40mg,

Recruiting
  • Metastatic Castration-Resistant Prostate Cancer (mCRPC)
  • Enzalutamide 40mg
  • +4 more
  • Bellinzona, Switzerland
  • +1 more
Nov 6, 2023

Advanced Solid Tumor, Advanced or Metastatic NSCLC Trial in Guanzhou, Chengdu (BBP-398)

Recruiting
  • Advanced Solid Tumor
  • Advanced or Metastatic Non-small Cell Lung Cancer
  • Guanzhou, Guangdong, China
  • +1 more
Nov 30, 2022

Metastatic Castration-resistant Prostate Cancer Trial in Australia (HP518 - Dose Escalation, HP518 - Dose expansion)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • HP518 - Dose Escalation
  • HP518 - Dose expansion
  • Albury, New South Wales, Australia
  • +4 more
May 5, 2022

Solid Tumor, Adult Trial in Tianjin (AK119, AK104)

Recruiting
  • Solid Tumor, Adult
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Insitute & Hospital
Dec 28, 2022

Metastatic Breast Cancer Trial in Springfield, Rochester, Lebanon (17B-estradiol, Letrozole, Anastrozole)

Active, not recruiting
  • Metastatic Breast Cancer
  • Springfield, Massachusetts
  • +2 more
Nov 1, 2022